Impact of hollow-fiber membrane surface area on oxygenator performance: Dideco D903 Avant versus a prototype with larger surface area.

This study compares the gas transfer capacity, the blood trauma, and the blood path resistance of the hollow-fiber membrane oxygenator Dideco D 903 with a surface area of 1.7 m2 (oxygenator 1.7) versus a prototype built on the same principles but with a surface area of 2 m2 (oxygenator 2). Six calves (mean body weight: 68.2 +/- 3.2 kg) were connected to cardiopulmonary bypass (CPB) by jugular venous and carotid arterial cannulation, with a mean flow rate of 4 l/min for 6 h. They were randomly assigned to oxygenator 1.7 (N = 3) or 2 (N = 3). After 7 days, the animals were sacrificed. A standard battery of blood samples was taken before the bypass, throughout the bypass, and 24 h, 48 h, and 7 days after the bypass. The oxygenator 2 group showed significantly better total oxygen and carbon dioxide transfer values throughout the perfusion (p < .001 for both comparison). Hemolytic parameters (lactate dehydrogenase and free plasma hemoglobin) exhibited a slight but significant increase after 5 h of bypass in the oxygenator 1.7 group. The pressure drop through the oxygenator was low in both groups (range, 43-74 mmHg). With this type of hollow-fiber membrane oxygenator, an increased surface of gas exchange from 1.7 m2 to 2 m2 improves gas transfer, with a limited impact on blood trauma and no increase of blood path resistance.

[1]  R C Eberhart,et al.  Mathematical and experimental methods for design and evaluation of membrane oxygenators. , 2008, Artificial organs.

[2]  J. Gaylor,et al.  Membrane oxygenators: influence of design on performance , 1994, Perfusion.

[3]  M. Turina,et al.  Improved Biocompatibility of Heparin Surface-Coated Ventricular Assist Devices , 1992, The International journal of artificial organs.

[4]  R. de Caterina,et al.  Blood - Artificial Surface Interactions during Cardiopulmonary Bypass , 1990, The International journal of artificial organs.

[5]  L. Segesser Determination of significant differences in performance of the Bentley BOS-CM 40 hollow fibre membrane oxygenator and the Polystan VT5000 venotherm bubble oxygenator , 1987 .

[6]  J. Soons,et al.  Hematological advantage of a membrane oxygenator over a bubble oxygenator in long perfusions. , 1986, The Annals of thoracic surgery.

[7]  A. Carpentier,et al.  Deleterious effects of cardiopulmonary bypass. A prospective study of bubble versus membrane oxygenation. , 1985, The Journal of thoracic and cardiovascular surgery.

[8]  C. Wildevuur,et al.  Two membrane oxygenators and a bubbler: a clinical comparison. , 1983, The Annals of thoracic surgery.

[9]  M. Dewanjee,et al.  Fate of indium 111-labeled platelets during cardiopulmonary bypass performed with membrane and bubble oxygenators. , 1982, The Journal of thoracic and cardiovascular surgery.

[10]  D. Stroncek,et al.  Complement activation and neutropenia occurring during cardiopulmonary bypass. , 1981, The Journal of thoracic and cardiovascular surgery.

[11]  E. Blackstone,et al.  Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins. , 1981, The New England journal of medicine.

[12]  J. D. Brooks,et al.  Comparison of bubble and membrane oxygenators in short and long perfusions. , 1979, The Journal of thoracic and cardiovascular surgery.

[13]  John J. Osborn,et al.  HEART-LUNG BYPASS: Principles and Techniques of Extracorporeal Circulation. , 1963 .

[14]  D. Holt,et al.  Oxygenators for Extracorporeal Circulation , 1995 .

[15]  C. Wildevuur,et al.  Clinical study of blood trauma during perfusion with membrane and bubble oxygenators. , 1982, The Journal of thoracic and cardiovascular surgery.

[16]  E. Stemmer,et al.  Erythrocyte survival following extracorporeal circulation. A question of membrane versus bubble oxygenator. , 1981, The Journal of thoracic and cardiovascular surgery.

[17]  J. D. Hellums,et al.  Erythrocyte damage and destruction induced by shearing stress. , 1968, The Journal of laboratory and clinical medicine.